Lenovo Shares Surge Nearly 20 as Record Revenue and Doubling AI Business Drive Optimism Nios LongTerm Growth Potential Possibility of Doubling by 2029 SpaceX S1 Disclosure Reveals AI Infrastructure Economics 27M per Megawatt and SubMonth Payback from Anthropic Contract Workday WDAY Captures Attention as Potential AI Growth Driver Gold Prices Face Potential Headwinds from Peace Talks and Rate Hike Concerns Retail Shareholding Declines in Major Indian Stocks During Q4 Ready Capital Corporation RC Q1 2026 Earnings Deep EPS Miss as Net Loss Exceeds Expectations EGBN Q1 2026 Earnings EPS Surges Past Estimates on Strong Margin and Lower Provisions CURR Q3 2025 Earnings Strong EPS Surprise as Profitability Emerges Revenue Details Not Disclosed Newmark Group Inc NMRK Q1 2026 Earnings Strong EPS Beat Drives Positive Sentiment MDU Q1 2026 Earnings EPS Misses Estimates but Stock Gains 15 Fresh Del Monte Produce Inc FDP Q1 2026 Earnings EPS Slightly Beats Estimates Amid Modest Stock Gain Valneva Shares Edge Higher as Price Action Tests Key Resistance Levels Gesher Acquisition Corp II Warrants GSHRW Hold Steady at 022 Amid Quiet Trading Vendome Acquisition Corp I VNME Holding Steady at 1017 Amid SPAC Market Stability Vantage Corp VNTG Surges 7 as Momentum Builds Toward Key Resistance MGRB Shows Modest Uptick as FixedIncome Security Holds Near Midpoint of Range Waymo Implements Temporary Pause on Robotaxi Operations in Five US Cities Following FloodRelated Incidents LOB Q1 2026 Earnings Strong EPS Beat Despite Modest Stock Pullback StoneBridge Acquisition II Corporation Units APACU Holds Steady at 1020 With No Net Change Regions Financial RF Gains 15 as Bank Sector Shows Resilience Lineage Cell Therapeutics LCTX Gains 3 as Biotech Sector Finds Support Tivic Health Systems TIVC Holds Steady at 140 Amidst Sideways Trading Opera OPRA Rallies 166 as Shares Test Key Resistance Near 1861 Shore Bancshares SHBI Edges Higher Approaching Key Resistance at 2149 Tri Pointe Homes Inc TPH Holds Steady Near 47 as Housing Sector Consolidates Nuvectis Pharma NVCT Declines 539 as Stock Tests Key Support Level